BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 28 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,647 | -9.0% | 82,000 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $1,809 | +37.4% | 70,900 | +14.5% | 0.00% | +50.0% |
| Q1 2023 | $1,317 | -99.9% | 61,900 | -59.6% | 0.00% | -33.3% |
| Q2 2022 | $2,571,000 | -9.0% | 153,200 | +137.9% | 0.00% | 0.0% |
| Q1 2022 | $2,826,000 | -36.6% | 64,399 | -12.0% | 0.00% | -50.0% |
| Q4 2021 | $4,454,000 | +905.4% | 73,179 | +401.2% | 0.01% | +500.0% |
| Q2 2021 | $443,000 | -44.7% | 14,600 | -45.5% | 0.00% | 0.0% |
| Q1 2021 | $801,000 | -45.1% | 26,800 | -67.0% | 0.00% | -50.0% |
| Q4 2020 | $1,458,000 | +28.7% | 81,200 | +36.5% | 0.00% | +100.0% |
| Q3 2020 | $1,133,000 | -3.7% | 59,500 | -20.3% | 0.00% | 0.0% |
| Q2 2020 | $1,176,000 | +357.6% | 74,700 | +297.3% | 0.00% | – |
| Q1 2020 | $257,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |